FDA Inspection 1234656 — Alejandra M. Villamil, M.D.
The FDA completed an inspection of Alejandra M. Villamil, M.D. on March 22, 2024 in Ciudad Autonoma Buenos Aires. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ciudad Autonoma Buenos Aires (Argentina)
Additional Details
Clinical Investigator (CI)